In the most recent presentation, page 15, there is a summary of the competitive positioning of XP vs the names you mention. The basic selling point as the company sees it, is that it will be the most capable and the cheapest handset on the market. They are making sales in Europe and ROW so one would assume there is a market for them there.
- Forums
- ASX - By Stock
- Ann: FDA Approval for Xprecia Prime
In the most recent presentation, page 15, there is a summary of...
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UBI (ASX) to my watchlist
(20min delay)
|
|||||
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $35.86M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 15.5¢ | $14.86K | 92.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10650 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 19606 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10650 | 0.155 |
1 | 37000 | 0.150 |
2 | 33684 | 0.135 |
4 | 170010 | 0.130 |
2 | 43666 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 19606 | 1 |
0.170 | 55000 | 1 |
0.180 | 22043 | 3 |
0.190 | 12000 | 1 |
0.195 | 30577 | 1 |
Last trade - 15.09pm 03/05/2024 (20 minute delay) ? |
|
|||||
Last
16.0¢ |
  |
Change
0.005 ( 10.3 %) |
|||
Open | High | Low | Volume | ||
15.5¢ | 16.0¢ | 15.5¢ | 48789 | ||
Last updated 10.33am 03/05/2024 ? |
Featured News
UBI (ASX) Chart |